Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
BMC Infect Dis ; 14: 553, 2014 Oct 22.
Artigo em Inglês | MEDLINE | ID: mdl-25330812

RESUMO

BACKGROUND: CD4+ T-cell testing of blood specimens collected in standard EDTA Vacutainer tubes and transported at ambient temperature, must be completed within 48 hours with the BD FACSCount™ flow cytometer, restricting specimen collection in remote clinics with no on-site testing and limited specimen transport services. We conducted a study in Buhera District, Zimbabwe, to assess the stability and accuracy of CD4+ T-cell results of samples collected in Stabilization Tubes (ST) and stored at ambient temperature for varying time periods. METHODS: Paired EDTA and ST samples were collected from 51 HIV-positive patients aged 18 years and older. CD4+ T-cell testing was done on arrival in the laboratory (Day 0). ST samples were retested on Days 3, 5, and 7. Nineteen ST samples were stored for an additional week and retested on Day 14. RESULTS: There was a strong correlation between absolute CD4+ T-cell counts measured in the EDTA Day 0 reference sample and Day 7 ST sample (Spearman's rho: 0.9778; mean difference: -4.9 cells/µL and limits of agreement (LOA): 98.5 and 88.7 cells/µL); and the reference sample and Day 14 ST sample (Spearman's rho: 0.9632; mean difference 5.1 cells/µL and LOA: -99.6 and 109.8 cells/µL. Using a 350 cells/µL threshold, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were all 100% on Day 7, and 83.3%, 100%, 100% and 92.9% on Day 14. Using a 500 cells/µL threshold, the sensitivity, specificity, PPV and NVP were 100%, 88.5%, 88.5% and 100% on Day 7 and 88.9%, 80.0%, 80.0% and 88.9% on Day 14. CONCLUSIONS: CD4 ST can be used and stored up to 7 days as a reliable alternative to standard EDTA tubes in settings where CD4+ T-cell testing within 48 hours is not feasible. Despite the small sample size, results suggest that ST may be stored up to 14 days at room temperature for CD4 testing, without compromising accuracy. However, further studies with larger sample sizes are needed to confirm this preliminary finding.


Assuntos
Coleta de Amostras Sanguíneas/instrumentação , Infecções por HIV/sangue , Adulto , Anticoagulantes/química , Coleta de Amostras Sanguíneas/métodos , Coleta de Amostras Sanguíneas/normas , Contagem de Linfócito CD4/instrumentação , Contagem de Linfócito CD4/métodos , Contagem de Linfócito CD4/normas , Linfócitos T CD4-Positivos/imunologia , Ácido Edético/química , Feminino , Citometria de Fluxo , Infecções por HIV/diagnóstico , Infecções por HIV/imunologia , Humanos , Masculino , Pessoa de Meia-Idade , Melhoria de Qualidade , População Rural , Sensibilidade e Especificidade , Meios de Transporte , Zimbábue
2.
PLoS One ; 12(9): e0184634, 2017.
Artigo em Inglês | MEDLINE | ID: mdl-28934344

RESUMO

STUDY GOALS: To describe the differences between clients presenting after rape and clients who have consented to sex as a minor to an SGBV clinic in Harare, Zimbabwe, and how these differences affect their care requirements. BACKGROUND: Adolescents and adults presenting at the specialized Sexual and Gender Based Violence clinic in Harare are offered a standardised package of free medical and psychosocial care. Zimbabwe has an HIV prevalence of 14%, so prevention of HIV infection using PEP for those that present within 72 hours is a key part of the response. STI treatment, emergency contraceptive pills, referral for termination of pregnancy, psychological, social and legal support is also provided. METHODS: This is a retrospective descriptive study of routine programmatic data collected at the Edith Opperman polyclinic in Mbare SGBV clinic from 2011 to 2014. Chi-square tests and logistic regression were used to describe the different experiences and the differences in uptake of care between clients presenting for rape compared to those who consented to sex as a minor. RESULTS: During the study period a total of 3617 clients presented to the clinic. 2242 (62%) sought care after rape, 602 (17%) for having consented to sex as a minor and 395 (11%) for suspected sexual abuse. 1615 (45%) of people presenting were 12-15 year olds. Minors who consented to sex compared to survivors of rape were less likely to report within 72 hours- 156 (26%) vs 894 (40%) p<0.001; less likely to report that they delayed due to fear- 68 (17%) vs 472 (40%) p<0.001, less likely to have experienced accompanying violence- 9 (1%) vs 176 (8%) p<0.001 or physical trauma-34 (6%) vs 427 (19%) p<0.001; and less likely to display psychological symptoms at presentation 51 (8%) vs 411 (18%) p<0.001. Minors who consented to sex compared to those who were raped were less likely to start PEP if eligible-123 (80%) vs 751 (93%) p<0.001, less likely to take emergency contraceptives if eligible-125 (81%) vs 598 (88%) p<0.001, more likely to be pregnant- 132 (23%) vs 241 (15%) p<0.001; less likely to request a termination of pregnancy if pregnant-10 (8%) vs 74 (31%) p<0.001; and less likely to come for at least one follow up 281 (47%) vs 1304 (58%) p<0.001. CONCLUSION: The experiences of those who consent to sex as a minor and those that have experienced forced sex were very different. The standardised SGBV medical response does not fully meet the needs to protect minors who have consented to sex from HIV or unwanted pregnancies. Clients who present for having consented to sex as a minor might benefit more from being offered long-term family planning or being assessed as a sero-discordant couple rather than simply PEP and ECP as is relevant for clients who have been raped. More provision of health care is needed for minors to ensure they have access to enough information and protection from HIV, other STIs and unwanted pregnancy, before they decide to engage in sexual intercourse, rather than as an emergency at an SGBV clinic.


Assuntos
Abuso Sexual na Infância , Serviços de Saúde , Menores de Idade , Estupro , Comportamento Sexual , Adolescente , Adulto , Fatores Etários , Criança , Anticoncepção Pós-Coito , Serviços Médicos de Emergência , Serviços de Planejamento Familiar , Feminino , Seguimentos , Infecções por HIV/prevenção & controle , Humanos , Masculino , Gravidez , Gravidez não Desejada , Estudos Retrospectivos , Fatores de Tempo , Adulto Jovem , Zimbábue
3.
J Agric Food Chem ; 57(19): 9011-5, 2009 Oct 14.
Artigo em Inglês | MEDLINE | ID: mdl-19739658

RESUMO

Acrylamide and pyrazine formation, as influenced by the incorporation of different amino acids, was investigated in sealed low-moisture asparagine-glucose model systems. Added amino acids, with the exception of glycine and cysteine and at an equimolar concentration to asparagine, increased the rate of acrylamide formation. The strong correlation between the unsubstituted pyrazine and acrylamide suggests the promotion of the formation of Maillard reaction intermediates, and in particular glyoxal, as the determining mode of action. At increased amino acid concentrations, diverse effects were observed. The initial rates of acrylamide formation remained high for valine, alanine, phenylalanine, tryptophan, glutamine, and leucine, while a significant mitigating effect, as evident from the acrylamide yields after 60 min of heating at 160 degrees C, was observed for proline, tryptophan, glycine, and cysteine. The secondary amine containing amino acids, proline and tryptophan, had the most profound mitigating effect on acrylamide after 60 min of heating. The relative importance of the competing effect of added amino acids for alpha-dicarbonyls and acrylamide-amino acid alkylation reactions is discussed and accompanied by data on the relative formation rates of selected amino acid-AA adducts.


Assuntos
Acrilamida/síntese química , Aminoácidos/administração & dosagem , Reação de Maillard , Pirazinas/síntese química , Acrilamida/análise , Acrilamida/química , Aminoácidos/química , Asparagina/química , Glucose/química , Glicina/farmacologia , Temperatura Alta , Modelos Químicos , Pirazinas/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA